Mizuho Medy Co.,Ltd.

¥1,672As of Sun 8 Nov 2026, 12:00 UTC
TSE:4595Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 24.73%
Div yield 5.98%
ROE 18.04%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.48
PE TTM 9.870
TSR TTM 8.80%
Mkt cap ¥31.85B
ROIC 53.54%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥1,843
10.25%
(67.88%)
Hold 5|12|1|2|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
17.62
16.78
16.38
15.76
19.51%
5.10%
(0.73%)
(7.18%)
Revenue¥B
1.422
1.401
1.396
1.423
0.41%
1.32%
(1.04%)
3.52%
Peers (US$202.2M)
Cap (US$)
PE
294.9M
14.89x
Capital
TTM
5Y
10Y
Leveragex
0.279
1.491
0.916
EBIT/Intx
0.132
0.259
0.291
Own earn%
74.93
(196.26)
(133.54)
Sh yield%
34.53
20.07
20.65
Owners
Insiders/Inst%
12.50
32.67
Short interest%
5.57
SBC / revenue%
2.00
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
7–18
$1 testx
—
Incr. ROIC%
2